Picchi Awards

The prestigious Picchi Awards, supported by the Picchi Brothers Foundation, aims to inspire and encourage the next generation of cancer research leaders.

Three outstanding PhD students have been chosen from the categories of basic science, clinical science and population health. Each award winner receives $10,000 to learn and build networks; providing support towards research independence.

The awards are available to PhD students who have confirmed candidature at a University affiliated with a VCCC Alliance partner and are undertaking cancer-related research training within a VCCC Alliance partner at the application closing date.

Award recipients


Basic Science: Stefan Bjelosevic, Peter MacCallum Cancer Centre
Investigating FMS-like tyrosine kinase 3 (FLT3)-induced metabolic reprogramming in acute myeloid leukaemia

Clinical Science: Deborah Meyran, Peter MacCallum Cancer Centre
New CAR-T cells to enhance paediatric immunotherapy

Population Health: Matthew Grant, St Vincent’s Hospital, Palliative Nexus Research Group, University of Melbourne
An exploration of informal communities in cancer treatment


Basic Science: Amanda Oliver, Peter MacCallum Cancer Centre 
Tissue-specific tumour microenvironments and their impact on immunotherapy responses

Clinical Science: Edward Chew, Walter and Eliza Hall Institute
Identification of novel genetic drivers in the development of acute myeloid leukemia

Population Health: Sibel Saya, University of Melbourne
The acceptability, feasibility and clinical utility of a genomic profile to target screening for colorectal cancer


Basic Science: Ms Simone Park, University of Melbourne - Doherty Institute 
The role of tissue-resident memory T cells in melanoma immune surveillance

Clinical Science: Dr Jonathan Hiller, Peter MacCallum Cancer Centre
Exploring perioperative adjunctive therapies that can be utilised during cancer surgery to improve cancer outcomes

Population Health: Dr Shuai Li, University of Melbourne
DNA methylation and breast cancer risk factors: insights from twin and family studies


Basic Science: Rebecca Delconte, Walter and Eliza Hall Institute and University of Melbourne
Targeting Regulators of Natural Killer Cell Homeostasis in Cancer Immunotherapy

Clinical Science: Kathryn Field, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne 
Towards the further understanding of prognosis and outcomes for patients with high grade gliomas: A randomised phase II study of Carboplatin and Bevacizumab in Recurrent Glioblastoma (CABARET study)

Population Health: Kevin Nguyen, University of Melbourne 
Breast Cancer Associations with Mammographic Density Defined by Higher Pixel Brightness Thresholds